September 26, 2018
Protecting Communities through effective Vector Control
Local News
Bayer initiates public dialogue on tackling vector borne diseases in India
August 28, 2018
Not intended for U.S. and UK Media
Bayer secures approval in the EU for Xarelto® (rivaroxaban) for patients with coronary or peripheral artery disease
Xarelto is the only non-vitamin K antagonist oral anticoagulant (NOAC) indicated in combination with acetylsalicylic acid (ASA) for the prevention of atherothrombotic events in patients with coronary artery disease or symptomatic peripheral artery disease at high risk for ischemic events / Launch first expected in Germany more
August 27, 2018
Bayer provides disaster relief
Bayer pledges financial assistance for flood victims in India
Company makes available €100,000 in immediate assistance for people impacted by the severe flooding in Kerala. more
August 17, 2018
Following completion of the divestment of Crop Science businesses to BASF
Bayer: Conditions for beginning Monsanto integration fulfilled
Legal remedies against jury verdict in California announced more
July 24, 2018
Bayer Foundation awards 26 scholarships for Science Camp during summer vacation
Young scientists experimenting on health and food science topics at Bayer Science Teens Camp in the U.S.
International exchange: Pupils from India, several African countries, the U.S. and Germany taking part in two-week, hands-on seminar focusing on life science, medical health and food science topics / Bayer partnering with renowned Center for STEM Learning at University of Colorado in Boulder more
.jpg)
June 08, 2018
Bayer closes Monsanto acquisition
more
June 08, 2018
A Better Life for farmers and their families with Arize hybrids
Bayer distributes scholarships under its ‘A for Arize’ education awareness initiative
20 students from 6 states will receive support to pursue higher education / Besides scholarships, ‘A for Arize’ initiative also aims to create awareness about the need for quality education more
